Clinical Trials · NCT06039826
A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 46
- Start date
- Sep 2023
- Locations
- 2 sites, United States
- Primary endpoint
- Pharmacokinetics (PK): Area Under the Concentration Versus Time Curve from Time zero to 24 Hours Postdose (AUC0-24) of Ethinyl Estradiol